Page 1 | Search Results | Blood | American Society of Hematology

1-18 of 18

Sort by

Sort Order Select

Journal Articles

Clinical Results of a Multicenter Study of the First-in-Human Dual BCMA and CD19 Targeted Novel Platform Fast CAR-T Cell Therapy for Patients with Relapsed/Refractory Multiple Myeloma

Blood (2020) 136 (Supplement 1): 25–26.

https://doi.org/10.1182/blood-2020-138614

Published: 2020

Journal Articles

Plasma Cell-Free DNA Chromosomal Instability As Surrogate Biomarker of Treatment Response and Minimal Residual Diseases for Multiple Myeloma

Juan Du, Jr., MD, Baoan Chen, MDPhD, Wanting Qiang, Yanchun Jia, Jing Lu, MD, Lu Li, Jing Liu, Hua Jiang, MD, Ziliang Qian, Weijun Fu, MDPhD

Blood (2020) 136 (Supplement 1): 29.

https://doi.org/10.1182/blood-2020-138783

Published: 2020

Journal Articles

Efficacy and Safety of CAR-T Therapy with Safety Switch Targeting Bcma for Patients with Relapsed/Refractory Multiple Myeloma in a Phase 1 Clinical Study

Weijun Fu, Sr., MD PhD, Juan Du, MD, Hua Jiang, MD, Zhi CHENG, MD, Runhong Wei, MD, Kang Yu, MD, Songfu Jiang, MD, Feng He, Hongliang Fang, PhD, Yarong Liu, PhD, Pin Wang

Blood (2019) 134 (Supplement_1): 3154.

https://doi.org/10.1182/blood-2019-127608

Published: 2019

Journal Articles

Monocytic Myeloid-Derived Suppress Cells Restore Adipogenic Bone Marrow Microenvironment in Aplastic Anemia By Inhibiting Intra-BM CD8 + T Cells Proliferation

Ying Qu, PhD, Zhengxu Sun, PhD, Yan Yuan, MD PhD, Fen Wang, PhD, Kunpeng Wu, MS, Yunfeng Cheng, MD PhD, Hua Jiang, MD PhD, Tong Chen, MD

Blood (2019) 134 (Supplement_1): 1211.

https://doi.org/10.1182/blood-2019-125059

Published: 2019

Journal Articles

A Busulfan Following Cyclophosphamide and Constant Cell Dose Protocol Improved Results in Alternative Donor Hematologic Stem Cell Transplantation in Thalassemia Major: A Result from Long-Term Large-Size Multi-Center Study

Yuelin He, MD, Hua Jiang, MD PhD, Changgang Li, MD, Yiping Zhu, MD, Xuedong Wu, MD PhD, Liu Sixi, MD PhD, Qu Yuhua, MD, Jiangyu Liao, MD, Xiaoqin Feng, Huaying Liu, MD, Zhiyong Peng, MD, Lan He, MD, Chaoke Bu, MD, Gautam Mandeen, MD, Leung Wing, MD PhD, Chunfu Li, MD

Blood (2019) 134 (Supplement_1): 970.

https://doi.org/10.1182/blood-2019-130202

Published: 2019

Journal Articles

Effect of Dasatinib Vs Imatinib in the Treatment of Pediatric Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: A Randomized, Open-Label, Multicenter Study of the Chinese Children's Cancer Group

Blood (2019) 134 (Supplement_1): 828.

https://doi.org/10.1182/blood-2019-126219

Published: 2019

Journal Articles

Durable Remission Achieved from Bcma-Directed CAR-T Therapy Against Relapsed or Refractory Multiple Myeloma

Yarong Liu, PhD, Zhi Chen, MD, Hongliang Fang, PhD, Runhong Wei, MD, Kang Yu, MD, Songfu Jiang, PhD, Weijun Fu, MDPhD, Hua Jiang, MD, Juan Du, PhD MD, Feng He, Ronglin Xie, Jing Chen, Baofeng Wei, Jin Tao, Pin Wang

Blood (2018) 132 (Supplement 1): 956.

https://doi.org/10.1182/blood-2018-99-112786

Published: 2018

Journal Articles

Novel MEIS1-FOXO1 Fusion Gene in a Case of Pediatric B-Cell Precursor Acute Lymphoblastic Leukemia

Chuang Jiang, PhD, Jiabi Qian, M.Sc, Wenge Hao, MD, Wei LIU, MD, Shuhong Shen, MD PhD, Hua Jiang, MD, Hui Zhang, PhD

Blood (2018) 132 (Supplement 1): 5283.

https://doi.org/10.1182/blood-2018-99-116354

Published: 2018

Journal Articles

Cell-Free DNA Analysis Demonstrates Comprehensive Genomic Profiling and a Facile Method to Sensitively in Multiple Myeloma

Juan Du, MD PhD, Jing Lu, Wanting Qiang, Lu Li, Jin Liu, Hua Jiang, MD, Ziliang Qian, PhD, Baoan Chen, MD PhD, Weijun Fu, MD PhD

Blood (2018) 132 (Supplement 1): 5603.

https://doi.org/10.1182/blood-2018-99-116260

Published: 2018

Journal Articles

Inherited NUDT15 Variants Substantially Increased Infection and Related Medical Cost in Children with Acute Lymphoblastic Leukemia

Jiabi Qian, M.Sc, Chuang Jiang, PhD, Qian Wenji, PhD, Wenge Hao, MD, Jiayi WANG, MD, Yingyi He, MD& PhD, Hua Jiang, MD, Yin Ting Cheung, PhD, Hui Zhang, PhD

Blood (2018) 132 (Supplement 1): 320.

https://doi.org/10.1182/blood-2018-99-114400

Published: 2018

Journal Articles

Related and Unrelated Donor Transplantation for β Thalassemia Major: Results of an International Survey

Blood (2018) 132 (Supplement 1): 308.

https://doi.org/10.1182/blood-2018-99-111152

Published: 2018

Journal Articles

Effective Treatment of Relapsed/Refractory Multiple Myeloma Including Extramedullary Involvement By BCMA-Specific Chimeric Antigen Receptor-Modified T Cells

Jian-Qing Mi, MD PhD, Xiaohu (Frank) Fan, PhD, Jie Xu, PhDMD, Yuanfang Liu, MD PhD, Yan Zhuang, PhD, Shuangshuang Yang, Wu Zhang, PhD, Bing Chen, MD PhD, Yueying Wang, PhD, Xiangqin Weng, Junmin Li, Weijun Fu, MD, Hua Jiang, MD, Li Zhu, Zhu Chen, PhD, Sai-Juan Chen, PhD, Jian Hou, PhD MD

Blood (2017) 130 (Supplement 1): 3115.

https://doi.org/10.1182/blood.V130.Suppl_1.3115.3115

Published: 2017

Journal Articles

A Multicenter Nonrandom Clinical Study of Induction Regimen of FLAG-ID and Dae in the Treatment of Childhood De Novo Acute Myeloid Leukemia in South of China:the Early Report of Efficacy and Safety

Jian Li, MD, Chunfu Li, MD, Hua Jiang, MD, Mincui Zheng, Xiangling He, Honggui Xu, Chun Chen, Hong Wen, Changgang Li, MD, Xiaoqin Feng, PhD

Blood (2017) 130 (Supplement 1): 3873.

https://doi.org/10.1182/blood.V130.Suppl_1.3873.3873

Published: 2017

Journal Articles

IgD Myeloma: Clinical Features and Outcome from a Multicenter Retrospective Study in Chinese and Korean of 308 Patients from Asian Myeloma Network (AMN) Project

Juan Du, PhD MD, Weijun Fu, MD, Jae Hoon Lee, MD PhD, Chunyang Zhang, MD, Kihyun Kim, MD, Ai Jun Liu, MD, Jin Lu, Cheolwon Suh, MD PhD, Min Kyoung Kim, MD PhD, Wenming Chen, MD, Jin Liu, Hua Jiang, MD, Jian Hou, PhD MD

Blood (2017) 130 (Supplement 1): 5409.

https://doi.org/10.1182/blood.V130.Suppl_1.5409.5409

Published: 2017

Journal Articles

Hematopoietic Stem Cell Transplantation from Full Matched Alternative Donor Has Same Results As Those from Matched Sibling for Patients with Beta-Thalassemia Major —a Large-Cohort Multicenter Study from China

Yuelin He, Hua Jiang, MD, Changgang Li, MD, Yiping Zhu, MD, Xuedong Wu, MD, Jianyun Liao, Hebi Jiang, Sixi Liu, MD, Xue Yang, Xiaoqin Feng, PhD, Yuqiong Ren, Chunfu Li, MD

Blood (2017) 130 (Supplement 1): 3329.

https://doi.org/10.1182/blood.V130.Suppl_1.3329.3329

Published: 2017

Journal Articles

Macrofocal Multple Myeloma Is a Particular Subgroup of Multiple Myeloma

Jianling Fan, MD, Jian Hou, MD PhD, Juan Du, MD PhD, Lina Jin, Lihui Peng, Baoan Chen, PhD Professor, Hao Xi, Hui Zhang, Hua Jiang, MD, Fan Zhou, Weijun Fu, MD

Blood (2015) 126 (23): 1855.

https://doi.org/10.1182/blood.V126.23.1855.1855

Published: 2015

Journal Articles

Micrornas Control Signaling Pathways and the Biologic Relevance in Multiple Myeloma Side Population Cells

Juan Du, MD, PhD, Shuyan Liu, Jie He, Wenqing Yan, Weijun Fu, MD, Hao Xi, Chunyang Zhang, Hua Jiang, MD, Jianling Fan, Jian Hou, MD, PhD

Blood (2012) 120 (21): 721.

https://doi.org/10.1182/blood.V120.21.721.721

Published: 2012

Journal Articles

Differential Expression of VEGF and Its Receptors in the Primary Cells of Various Risk Classified Acute Lymphoblastic Leukemia Patients.

Aibin Liang, MD, Li Li, MS, Long-Jun Gu, MD, Hua Jiang, MD, Hui Ye, MD

Blood (2004) 104 (11): 4446.

https://doi.org/10.1182/blood.V104.11.4446.4446

Published: 2004

NARROW

Clinical Results of a Multicenter Study of the First-in-Human Dual BCMA and CD19 Targeted Novel Platform Fast CAR-T Cell Therapy for Patients with Relapsed/Refractory Multiple Myeloma

Plasma Cell-Free DNA Chromosomal Instability As Surrogate Biomarker of Treatment Response and Minimal Residual Diseases for Multiple Myeloma

Efficacy and Safety of CAR-T Therapy with Safety Switch Targeting Bcma for Patients with Relapsed/Refractory Multiple Myeloma in a Phase 1 Clinical Study

Monocytic Myeloid-Derived Suppress Cells Restore Adipogenic Bone Marrow Microenvironment in Aplastic Anemia By Inhibiting Intra-BM CD8 + T Cells Proliferation

A Busulfan Following Cyclophosphamide and Constant Cell Dose Protocol Improved Results in Alternative Donor Hematologic Stem Cell Transplantation in Thalassemia Major: A Result from Long-Term Large-Size Multi-Center Study

Effect of Dasatinib Vs Imatinib in the Treatment of Pediatric Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: A Randomized, Open-Label, Multicenter Study of the Chinese Children's Cancer Group

Durable Remission Achieved from Bcma-Directed CAR-T Therapy Against Relapsed or Refractory Multiple Myeloma

Novel MEIS1-FOXO1 Fusion Gene in a Case of Pediatric B-Cell Precursor Acute Lymphoblastic Leukemia

Cell-Free DNA Analysis Demonstrates Comprehensive Genomic Profiling and a Facile Method to Sensitively in Multiple Myeloma

Inherited NUDT15 Variants Substantially Increased Infection and Related Medical Cost in Children with Acute Lymphoblastic Leukemia

Related and Unrelated Donor Transplantation for β Thalassemia Major: Results of an International Survey

Effective Treatment of Relapsed/Refractory Multiple Myeloma Including Extramedullary Involvement By BCMA-Specific Chimeric Antigen Receptor-Modified T Cells

A Multicenter Nonrandom Clinical Study of Induction Regimen of FLAG-ID and Dae in the Treatment of Childhood De Novo Acute Myeloid Leukemia in South of China:the Early Report of Efficacy and Safety

IgD Myeloma: Clinical Features and Outcome from a Multicenter Retrospective Study in Chinese and Korean of 308 Patients from Asian Myeloma Network (AMN) Project

Hematopoietic Stem Cell Transplantation from Full Matched Alternative Donor Has Same Results As Those from Matched Sibling for Patients with Beta-Thalassemia Major —a Large-Cohort Multicenter Study from China

Macrofocal Multple Myeloma Is a Particular Subgroup of Multiple Myeloma

Micrornas Control Signaling Pathways and the Biologic Relevance in Multiple Myeloma Side Population Cells

Differential Expression of VEGF and Its Receptors in the Primary Cells of Various Risk Classified Acute Lymphoblastic Leukemia Patients.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only